Dynavax Initiates Phase I Trial Of Hepatitis B Therapy
Fri, 02 Mar 2007 08:00 AM EST
... Dynavax Technologies Corporation (Nasdaq: DVAX) today announced that it had initiated a Phase 1 trial of its novel therapy for chronic hepatitis B virus (HBV) infection. The trial is being conducted in Hamburg, Germany and will enroll 20 healthy subjects to evaluate the safety of the therapy at two dosing schedules. [click link for full article] ...
Related Topics
- Clinical Trials
- Hepatitis C
- Hepatitis B
- Hepatitis A
- Hepatitis
- Hepatitis A and Hepatitis B Vaccine
- Hepatitis A Vaccine
- Color Therapy
- Music therapy
- Massage therapy
- Hepatitis B Vaccine
- Pet Therapy
- Physical Therapy
- Chelation therapy
- Natural therapy
- Natural therapies
- Autoimmune Hepatitis
- Magnet therapy
- Herbal therapy
- Urine therapy

Not Signed In -


